Inventor · disambiguated record
Marcin Kowanetz
Also filed as: KOWANETZ MARCIN · KOWANETZ MARCIN L · KOWANETZ MARCIN LESZEK
6 granted patents·29 pending applications·13 citations·filing 2010–2025
77Inventor score
Files withGENENTECH INC23BOLT BIOTHERAPEUTICS INC7VENTANA MED SYST INC3FERRARA NAPOLEONE1FOUND MEDICINE INC1
Top patents by PatentIndex Score
35 records- 0192US10689445B2Anti-PD-L1 antibodies and diagnostic uses thereofVENTANA MED SYST INC·Filed 2017·Granted Jun 23, 2020·6 cites·28 claims
- 0290US11300570B2Therapeutic and diagnostic methods for cancerGENENTECH INC·Filed 2019·Granted Apr 12, 2022·3 cites·18 claims
- 0388US2025093359A1Biomarkers and methods of treating pd-1 and pd-l1 related conditionsGENENTECH INC·Filed 2024·Application pending·0 cites
- 0488US2025052759A1Biomarkers and methods of treating pd-1 and pd-l1 related conditionsGENENTECH INC·Filed 2024·Application pending·0 cites
- 0583US11535671B2Therapeutic and diagnostic methods for cancerGENENTECH INC·Filed 2019·Granted Dec 27, 2022·2 cites·33 claims
- 0678US2023159641A1Anti-pd-l1 antibodies and diagnostic uses thereofVENTANA MED SYST INC·Filed 2022·Application pending·0 cites
- 0778US2024190967A1Therapeutic and diagnostic methods for cancerGENENTECH INC·Filed 2023·Application pending·0 cites
- 0876US2025306027A1Therapeutic and diagnostic methods for cancerGENENTECH INC·Filed 2025·Application pending·0 cites
- 0975US2022146517A1Biomarkers and methods of treating pd-1 and pd-l1 related conditionsGENENTECH INC·Filed 2021·Application pending·0 cites
- 1074US2022412981A1Therapeutic and diagnostic methods for cancerGENENTECH INC·Filed 2022·Application pending·0 cites
- 1173US2025164494A1Biomarkers and methods of treating pd-1 and pd-l1 related conditionsGENENTECH INC·Filed 2025·Application pending·0 cites
- 1273US2020041520A1Biomarkers and methods of treating pd-1 and pd-l1 related conditionsGENENTECH INC·Filed 2019·Application pending·0 cites
- 1373US2021140967A1Biomarkers and methods of treating pd-1 and pd-l1 related conditionsGENENTECH INC·Filed 2021·Application pending·0 cites
- 1471US11530269B2Anti-PD-L1 antibodies and diagnostic uses thereofVENTANA MED SYST INC·Filed 2020·Granted Dec 20, 2022·0 cites·20 claims
- 1571US2019195882A1Biomarkers and methods of treating pd-1 and pd-l1 related conditionsGENENTECH INC·Filed 2019·Application pending·0 cites
- 1670US2020333348A1Biomarkers and methods of treating pd-1 and pd-l1 related conditionsGENENTECH INC·Filed 2020·Application pending·0 cites
- 1769US2022073623A1Therapeutic and diagnostic methods for cancerGENENTECH INC·Filed 2021·Application pending·0 cites
- 1869US2018313845A1Biomarkers and methods of treating pd-1 and pd-l1 related conditionsGENENTECH INC·Filed 2018·Application pending·0 cites
- 1968US11254987B2PD-L1 promoter methylation in cancerGENENTECH INC·Filed 2017·Granted Feb 22, 2022·2 cites·20 claims
- 2063US2017052188A1Biomarkers and methods of treating pd-1 and pd-l1 related conditionsGENENTECH INC·Filed 2016·Application pending·0 cites
- 2162US2015071910A1Biomarkers and methods of treating pd-1 and pd-l1 related conditionsGENENTECH INC·Filed 2014·Application pending·0 cites
- 2261US2022195066A1Anti-cea immunoconjugates, and uses thereofBOLT BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2353US2024033370A1Anti-pd-l1 immunoconjugates, and uses thereofBOLT BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2453US2024238430A1Anti-cea immunoconjugates, and uses thereofBOLT BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2552US11299544B2Biomarkers and methods of treating PD-1 and PD-L1 related conditionsGENENTECH INC·Filed 2015·Granted Apr 12, 2022·0 cites·26 claims
- 2651US2023069055A1Anti-pd-l1 antibodiesBOLT BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2751US2023165968A1Cancer treatment methodsBOLT BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2850US2018037655A1Therapeutic and diagnostic methods for cancerGENENTECH INC·Filed 2017·Application pending·0 cites
- 2949US2018030138A1Therapeutic and diagnostic methods for cancerGENENTECH INC·Filed 2017·Application pending·0 cites
- 3049US2020157635A1Diagnostic and therapeutic methods for cancerGENENTECH INC·Filed 2019·Application pending·0 cites
- 3149US2023086603A1Anti-pd-l1 antibodiesBOLT BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3248US2016009805A1Anti-pd-l1 antibodies and diagnostic uses thereofGENENTECH INC·Filed 2015·Application pending·0 cites
- 3346US2022152215A1Immunoconjugates Targeting CEABOLT BIOTHERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3446US2018363066A1Methods and systems for evaluating tumor mutational burdenFOUND MEDICINE INC·Filed 2018·Application pending·0 cites
- 3534US2011027275A1Inhibition of tumor metastasisFERRARA NAPOLEONE·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Marcin Kowanetz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →